ليتروزول تيڤع

Negara: Israel

Bahasa: Arab

Sumber: Ministry of Health

Bahan aktif:

LETROZOLE 2.5 MG

Tersedia dari:

TEVA PHARMACEUTICAL INDUST.LTD

Kode ATC:

L02BG04

Bentuk farmasi:

TABLETS

Rute administrasi :

PER OS

Diproduksi oleh:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Kelompok Terapi:

LETROZOLE

Indikasi Terapi:

Letrozole teva tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined, locally advanced or metastatic breast cancer: Letrozole teva is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Tanggal Otorisasi:

2010-01-01